Stoke Gets Runway, Biogen A Late-Stage Asset In Epilepsy Collaboration

 
• By Joseph Haas
  
Epilepsy
Stoke is partnering with Biogen on its antisense candidate for a rare type of epilepsy

More from Advanced Therapies

More from Therapy Areas